Posts by KCAS Bio
Blogs
KCAS Bio will be at the 18th EBF Open Symposium : “Tuning in to Tomorrow: Science in High Definition.” Connecting with the Bioanalytical Community Like every year, our team will be on site to reconnect with the with the bioanalytical community, exchange ideas, and discuss the latest developments in…
News
OLATHE, Kan.–(BUSINESS WIRE)–KCAS Bio, a leading contract research organization (CRO) specializing in comprehensive bioanalytical and biomarker services, is delighted to announce the appointment of Dr. Paul Kirchgraber and Mr. Kurt Doyle to its Board of Directors. Their addition marks a significant milestone in KCAS Bio’s continued growth and strategic evolution…
webinars
In drug development, there is a growing demand for ultrasensitive bioanalytical platforms and kits, especially in disciplines like neuroscience, where analytes are often present at very low concentrations in peripheral circulation. KCAS Bio addresses this demand by offering a spectrum of technologies, from dedicated platforms to ultra-sensitive kits on conventional…
webinars
In the evolving landscape of drug development, biomarkers are increasingly vital in driving decisions across preclinical and clinical studies. From patient stratification and efficacy monitoring to safety assessments and pharmacodynamic evaluations, biomarkers are critical tools for reducing development timelines and increasing the likelihood of regulatory success. But with so many…
October 9
- October 9
KCAS Bio is excited to sponsor the upcoming Pharmaceutical & BioScience Society (PBSS) workshop “Pharmacokinetics in Drug Discovery and Development: Fundamentals, Applications and Case Studies,” on October 9th from 8:45am – 5:30pm PST in Foster City, California at the Crowne Plaza Hotel. Advanced Pharmacokinetics for Small Molecules and Biologics…
November 18
- November 18
Spots are limited! Please confirm attendance by filling out the form below. During EBF 2025 in Barcelona, KCAS Bio is pleased to welcome special guests and clients for an evening at La Pedrera – Casa Millá. Tuesday | 18 November 2025 | 8:10pm With your special entry, you’ll…
Blogs
KCAS Bio is engaging with the scientific community in Europe throughout the fall of 2025. From attending sessions to exhibiting at booths, our experts are ready to share knowledge, showcase our capabilities, and discuss how we can support your research across discovery and clinical development. EUROTOX 2025 CongressDate: September…
Blogs
KCAS Bio is connecting with the scientific community at key U.S. events this year. Whether attending or exhibiting, our experts are ready to share insights, highlight our capabilities, and discuss how we can support your research from discovery through clinical development. NCCG Annual Meeting 2025 Date: September 22, 2025Location:…
November 18
- November 20
Join KCAS Bio at the 18th EBF Open Symposium, taking place in Barcelona, Spain, on November 18-20. This event will bring together scientists from around the globe to discuss a broad array of bioanalytical topics. With the theme “Tuning in to Tomorrow,” The EBF Open Symposium will include strategic presentations…
November 16
- November 19
KCAS Bio will participate in the ACT 46th Annual Meeting, taking place November 16-19 in Phoenix, Arizona. The ACT Meeting gathers the toxicology community for four days of scientific exchange, networking, and professional development. With a strong focus on applied toxicology, the meeting features a robust scientific program, including symposia,…
November 11
- November 15
KCAS Bio will participate in the AMP 2025 Annual Meeting & Expo, taking place November 11-15 in Boston, MA. The AMP 2025 Annual Meeting brings together industry leaders and experts focused on advancing molecular diagnostics and precision medicine. The event covers the latest innovations in biomarker discovery, genomic testing, assay…
November 9
- November 12
KCAS Bio will participate in AAPS 2025 PharmSci 360, taking place November 9-12 in San Antonio, TX. Stop by Booth #3034 to meet our team in person. Don’t miss Dawn Dufield, Ph.D.’s session where she’ll discuss “Bioanalytical Strategies for Therapeutic Drugs and Their Conjugates (ADCs, Oligos, siRNA, ASOs and…